View in EDS

Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for ALS.

Saved in:
Bibliographic Details
Title: Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for ALS.
Authors: Miller, T.1 miller.t@wustl.edu, Cudkowicz, M.2, Shaw, P. J.3, Andersen, P. M.4, Atassi, N.2, Bucelli, R. C.1, Genge, A.5, Glass, J.6, Ladha, S.7, Ludolph, A. L.8, Maragakis, N. J.9, McDermott, C. J.3, Pestronk, A.1, Ravits, J.10, Salachas, F.11, Trudell, R.12, Van Damme, P.13, Zinman, L.14, Bennett, C. F.15, Lane, R.15
Source: New England Journal of Medicine. 7/9/2020, Vol. 383 Issue 2, p109-119. 11p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 144647260
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for ALS.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Miller%2C+T%2E%22">Miller, T.</searchLink><relatesTo>1</relatesTo><i> miller.t@wustl.edu</i><br /><searchLink fieldCode="AR" term="%22Cudkowicz%2C+M%2E%22">Cudkowicz, M.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Shaw%2C+P%2E+J%2E%22">Shaw, P. J.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Andersen%2C+P%2E+M%2E%22">Andersen, P. M.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Atassi%2C+N%2E%22">Atassi, N.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Bucelli%2C+R%2E+C%2E%22">Bucelli, R. C.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Genge%2C+A%2E%22">Genge, A.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Glass%2C+J%2E%22">Glass, J.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Ladha%2C+S%2E%22">Ladha, S.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Ludolph%2C+A%2E+L%2E%22">Ludolph, A. L.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Maragakis%2C+N%2E+J%2E%22">Maragakis, N. J.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22McDermott%2C+C%2E+J%2E%22">McDermott, C. J.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Pestronk%2C+A%2E%22">Pestronk, A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Ravits%2C+J%2E%22">Ravits, J.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Salachas%2C+F%2E%22">Salachas, F.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Trudell%2C+R%2E%22">Trudell, R.</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Van+Damme%2C+P%2E%22">Van Damme, P.</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Zinman%2C+L%2E%22">Zinman, L.</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22Bennett%2C+C%2E+F%2E%22">Bennett, C. F.</searchLink><relatesTo>15</relatesTo><br /><searchLink fieldCode="AR" term="%22Lane%2C+R%2E%22">Lane, R.</searchLink><relatesTo>15</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22New+England+Journal+of+Medicine%22">New England Journal of Medicine</searchLink>. 7/9/2020, Vol. 383 Issue 2, p109-119. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=144647260
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1056/NEJMoa2003715
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 109
    Titles:
      – TitleFull: Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for ALS.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Miller, T.
      – PersonEntity:
          Name:
            NameFull: Cudkowicz, M.
      – PersonEntity:
          Name:
            NameFull: Shaw, P. J.
      – PersonEntity:
          Name:
            NameFull: Andersen, P. M.
      – PersonEntity:
          Name:
            NameFull: Atassi, N.
      – PersonEntity:
          Name:
            NameFull: Bucelli, R. C.
      – PersonEntity:
          Name:
            NameFull: Genge, A.
      – PersonEntity:
          Name:
            NameFull: Glass, J.
      – PersonEntity:
          Name:
            NameFull: Ladha, S.
      – PersonEntity:
          Name:
            NameFull: Ludolph, A. L.
      – PersonEntity:
          Name:
            NameFull: Maragakis, N. J.
      – PersonEntity:
          Name:
            NameFull: McDermott, C. J.
      – PersonEntity:
          Name:
            NameFull: Pestronk, A.
      – PersonEntity:
          Name:
            NameFull: Ravits, J.
      – PersonEntity:
          Name:
            NameFull: Salachas, F.
      – PersonEntity:
          Name:
            NameFull: Trudell, R.
      – PersonEntity:
          Name:
            NameFull: Van Damme, P.
      – PersonEntity:
          Name:
            NameFull: Zinman, L.
      – PersonEntity:
          Name:
            NameFull: Bennett, C. F.
      – PersonEntity:
          Name:
            NameFull: Lane, R.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 07
              Text: 7/9/2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 00284793
          Numbering:
            – Type: volume
              Value: 383
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: New England Journal of Medicine
              Type: main
ResultId 1